Phathom Pharmaceuticals, Inc. (PHAT)
11.87
-1.18
(-9.04%)
USD |
NASDAQ |
May 15, 16:00
11.87
0.00 (0.00%)
After-Hours: 20:00
Phathom Pharmaceuticals Shareholders Equity (Quarterly) : -336.96M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 562.30M |
| Ligand Pharmaceuticals, Inc. | 997.32M |
| Axsome Therapeutics, Inc. | 54.59M |
| Corcept Therapeutics, Inc. | 637.99M |
| Assertio Holdings, Inc. | 75.63M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 305.12M |
| Total Liabilities (Quarterly) | 642.08M |
| Debt to Equity Ratio | -1.624 |
| Current Ratio | 2.212 |
| Net Debt Paydown Yield | 0.18% |